Androgen therapy in women, beyond libido

References

• Davis SR, Panjari M, Stanczyk FZ. DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011; 96:1642–53
   PubMed Web of Science ®Google Scholar
• Panjari M, Davis SR. Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas 2011;70:22–5
   PubMed Web of Science ®Google Scholar
• David K, Dingemanse E, Freud J, Laqueur E. Uber krystallinisches mannliches Hormon aus Hoden (Testosteron) wirksamer als aus harn oder aus Cholesterin bereitetes Androsteron. Hoppe Seylers Z Physiol Chem 1935;233:281
   Google Scholar
• Butenandt A, Hanisch G. Uber Testosterone. Umwandlung des Dehydro-Androsterons in Androstendiol und Testosteron; ein Weg zur Darstellung des Testosterons aus Cholestrin. Hoppe Seylers Z Physiol Chem 1935;237:89
   Google Scholar
• Engstrom WW, Munson PL. Studies on the metabolism of testosterone in normal women in different phases of the menstrual cycle. J Clin Endocrinol Metab 1951;11:427–33
   PubMed Web of Science ®Google Scholar
• Hallberg O, Nohrman B, Sylven B. Survival time in women with disseminated breast cancer, following testosterone treatment. Acta Radiol 1953;39:161–8
   PubMed Web of Science ®Google Scholar
• Davis MB. The use of testosterone in women with recurrent breast cancer. J Tennessee State Med Assoc 1948;41:213–18
   PubMedGoogle Scholar
• Moehlig RC, Gerisch RA. Methyl testosterone for migraine of women. J Michigan State Med Soc 1949;48:1025–8
   PubMedGoogle Scholar
• Burdine WE, Shipley TE, Papas AT. Delatestryl, a long-acting androgenic hormone; its use as an adjunct in the treatment of women with sexual frigidity. Fertil Steril 1957;8:255–9
   PubMed Web of Science ®Google Scholar
• Greenblatt RB. The use of androgens in the menopause and other gynecic disorders. Obstet Gynecol Clin North Am 1987;14:251–68
   PubMed Web of Science ®Google Scholar
• Simpson ER, Davis SR. Minireview: aromatase and the regulation of estrogen biosynthesis – some new perspectives. Endocrinology 2001;142:4589–94
   PubMed Web of Science ®Google Scholar
• Dunn JF, Nisula BC, Rodboard D. Transport of steroid hormones. Binding of 21 endogenous steroids to both testosterone-binding globulin and cortico-steroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58–68
   PubMed Web of Science ®Google Scholar
• Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995; 80:1429–30
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847–53
   PubMed Web of Science ®Google Scholar
• Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622–9
   PubMed Web of Science ®Google Scholar
• Bosdou JK, Venetis CA, Kolibianakis EM, et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 2012;18:127–45
   PubMed Web of Science ®Google Scholar
• Goldstat R, Briganti E, Tran J, Wolfe R, Davis S. Transdermal testosterone improves mood, well being and sexual function in premenopausal women. Menopause 2003;10:390–8
   PubMed Web of Science ®Google Scholar
• Davis SR, Papalia MA, Norman RJ, et al. Safety and efficacy of a testosterone metered-dose transdermal spray for treatment of decreased sexual satisfaction in premenopausal women: a placebo-controlled randomized, dose-ranging study. Ann Intern Med 2008;148:569–77
   PubMed Web of Science ®Google Scholar
• Shifren JL, Braunstein G, Simon J, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682–8
   PubMed Web of Science ®Google Scholar
• Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226–33
   PubMed Web of Science ®Google Scholar
• Braunstein G, Shifren J, Simon J, Lucas J, Rodenberg C, Watts NB. Testosterone patches for the treatment of low sexual desire in surgically menopausal women. Proceedings of the 14th Annual Meeting of the North American Menopause Society, 2003
   Google Scholar
• Davis SR, van der Mooren MJ, van Lunsen RHW, et al. The efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 2006;13:387–96
   PubMed Web of Science ®Google Scholar
• Shifren J, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study. Menopause 2006;13:770–9
   PubMed Web of Science ®Google Scholar
• Panay N, Al-Azzawi F, Bouchard C, et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010;13:121–31
   PubMed Web of Science ®Google Scholar
• Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in menopausal women not taking estrogen therapy. N Engl J Med 2008;359:2005–17
   PubMed Web of Science ®Google Scholar
• Baldassarre M, Perrone AM, Giannone FA, et al. Androgen receptor expression in the human vagina under different physiological and treatment conditions. Int J Impot Res 2013;25:7–11
   PubMed Web of Science ®Google Scholar
• Leiblum S, Bachmann GA, Kemmann E, Colburn D, Schwartzman L. The importance of sexual activity and hormones. JAMA 1983;249:2195
   PubMed Web of Science ®Google Scholar
• Witherby S, Johnson J, Demers L, et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. Oncologist 2011;16:424–31
   PubMed Web of Science ®Google Scholar
• Dubois V, Laurent M, Boonen S, Vanderschueren D, Claessens F. Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. Cell Molec Life Sci 2012;69:1651–67
   PubMed Web of Science ®Google Scholar
• Davis SR, Walker KZ, Strauss BJ. Effects of estradiol with and without testosterone on body composition and relationships with lipids in post-menopausal women. Menopause 2000; 7:395–401
   PubMed Web of Science ®Google Scholar
• Dobs AS, Nguyen T, Pace C, Roberts C. Differential effects of oral estrogen versus estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 2002;87:1509–16
   PubMed Web of Science ®Google Scholar
• Miller KK, Biller BM, Beauregard C, et al. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006;91:1683–90
   PubMed Web of Science ®Google Scholar
• Miller KK, Lawson EA, Mathur V, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2007;92:1334–9
   PubMed Web of Science ®Google Scholar
• Lawson EA, Miller KK, Bredella MA, et al. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 2010;46:458–63
   PubMed Web of Science ®Google Scholar
• Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia, Sarcopenia and Muscle 2011;2:153–61
   PubMed Web of Science ®Google Scholar
• Kasperk CH, Wergedal JE, Farley JR, Llinkhart TA, Turner RT, Baylink DG. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 1989;124:1576–8
   PubMed Web of Science ®Google Scholar
• Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri- and postmenopausal women. J Clin Invest 1996;97: 14–21
   PubMed Web of Science ®Google Scholar
• Lee JS, LaCroix AZ, Wu L, et al. Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women. J Clin Endocrinol Metab 2008;93:1796–803
   PubMed Web of Science ®Google Scholar
• Davis SR, McCloud PI, Strauss BJG, Burger HG. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227–36
   PubMed Web of Science ®Google Scholar
• Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995;85:529–37
   PubMed Web of Science ®Google Scholar
• Davis SR. Cardiovascular and cancer safety of testosterone in women. Curr Opin Endocrinol Diabetes Obes 2011;18: 198–203
   PubMed Web of Science ®Google Scholar
• Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis 2007;18:9–13
   PubMed Web of Science ®Google Scholar
• Bernini G, Sgro M, Moretti A. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 1999;84:2008
   PubMed Web of Science ®Google Scholar
• Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B, Van den Brande P. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy. Eur J Endocrinol 2007;156:687–93
   PubMed Web of Science ®Google Scholar
• Naessen T, Sjogren U, Bergquist J, Larsson M, Lind L, Kushnir MM. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. J Clin Endocrinol Metab 2010;95:1889–97
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil 2000;3:101–5
   PubMedGoogle Scholar
• Chou TM, Sudhir K, Hutchison SJ, et al. Testosterone induces dilation of canine coronary conductance and resitstance arteries in vivo. Circulation 1996;94:2614
   PubMed Web of Science ®Google Scholar
• Davison S, Thipphawong J, Blanchard J, et al. Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women. J Clin Pharmacol 2005;45:177–84
   PubMed Web of Science ®Google Scholar
• Worboys S, Kotsopoulos D, Teede H, McGrath BP, Davis SR. Parental testosterone improves endothelium-dependent and independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 2001;86:158–61
   PubMed Web of Science ®Google Scholar
• Lellamo F, Volterrani M, Caminiti G, et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol 2010; 56:1310–16
   PubMed Web of Science ®Google Scholar
• Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582–9
   PubMed Web of Science ®Google Scholar
• Davis SR, Goldstat R, Papalia MA, et al. Effects of aromatase inhibition on sexual function and wellbeing in postmenopausal women treated with testosterone: a randomized placebo controlled trial. Menopause 2006;13:37–45
   PubMed Web of Science ®Google Scholar
• Chiuve SE, Martin LA, Campos H, Sacks FM. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. J Clin Endocrinol Metab 2004;89:2207–13
   PubMed Web of Science ®Google Scholar
• Wagner JD, Zhang L, Williams JK, et al. Esterified estrogens with and without methyltesterone decrease arterial LDL metabolism in Cynomolgus monekys. Arteriosclerosis,Thrombosis & Vascular Biol 1996;16:1473–80
   PubMed Web of Science ®Google Scholar
• Zang H, Carlstrom K, Arner P, Hirschberg AL. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 2006;86:136–44
   PubMed Web of Science ®Google Scholar
• Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152–63
   PubMed Web of Science ®Google Scholar
• Nestler JE, Strauss JF 3rd. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991;20:807–23
   PubMed Web of Science ®Google Scholar
• Janssen I, Powell LH, Kazlauskaite R, Dugan SA. Testosterone and visceral fat in midlife women: the Study of Women’s Health Across the Nation (SWAN) fat patterning study. Obesity (Silver Spring) 2010;18:604–10
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Schwartz SM, Wellons MF, et al. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the ‘Coronary Artery Risk Development in Young Adults’ women’s study. J Clin Endocrinol Metab 2010;95:4424–31
   PubMed Web of Science ®Google Scholar
• Ouyang P, Vaidya D, Dobs A, et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009;204: 255–61
   PubMed Web of Science ®Google Scholar
• Worsley R, Robinson PJ, Bell RJ, Moufarage A, Davis SR. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause 2013 March 25. Epub ahead of print
   Web of Science ®Google Scholar
• Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest 2007;117:3979–87
   PubMed Web of Science ®Google Scholar
• Bixo M, Backstrom T, Winblad B, Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 1995; 55:297–303
   PubMed Web of Science ®Google Scholar
• Pike CJ, Carroll JC, Rosario ER, Barron AM. Protective actions of sex steroid hormones in Alzheimer’s disease. Front Neuroendocrinol 2009;30:239–58
   PubMed Web of Science ®Google Scholar
• Moller MC, Bartfai AB, Radestad AF. Effects of testosterone and estrogen replacement on memory function. Menopause 2010; 17:983–9
   PubMed Web of Science ®Google Scholar
• Wisniewski A, Ngyuen T, Dobs AS. Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women. Horm Res 2002;58:150–5
   PubMed Web of Science ®Google Scholar
• Shah SM, Bell RJ, Savage G, et al. Testosterone aromatization and cognition in women: a randomized placebo controlled trial. Menopause 2006;13:600–8
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell RJ, Gavrilescu M, et al. Testosterone improves verbal learning and memory in postmenopausal women: Results from a pilot study. Maturitas 2011;70:307–11
   PubMed Web of Science ®Google Scholar
• Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 2006; 166:1483–9
   PubMed Web of Science ®Google Scholar
• Jick SS, Hagberg KW, Kaye JA, Jick H. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Obstet Gynecol 2009;113:74–80
   PubMed Web of Science ®Google Scholar
• Ness RB, Albano J, McTiernan A, Cauley J. Influence of estrogen plus testosterone supplementation on breast cancer. Arch Intern Med 2009;169:41–6
   PubMed Web of Science ®Google Scholar
• Dimitrakakis C, Jones R, Liu A, Bondy CA. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 2004;11: 531–5
   PubMed Web of Science ®Google Scholar
• Davis SR, Wolfe R, Farrugia H, Ferdinand A, Bell RJ. The incidence of invasive breast cancer among women prescribed testosterone for low libido. J Sex Med 2009;6:1850–6
   PubMed Web of Science ®Google Scholar
• Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009; 19:398–405
   PubMed Web of Science ®Google Scholar
• Somboonporn W, Davis S, Seif M, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005, updated 2009:CD004509
   Google Scholar
• Eden JA. A pilot study of Andro-feme cream (1% testosterone). Proceedings of the 4th Annual Congress of the Australasian Menopause Society, Adelaide, Australia, 2000
   Google Scholar
• Snabes MC, Simes SM. Approved hormonal treatments for HSDD: an unmet medical need. J Sex Med 2009;6:1846–9
   PubMed Web of Science ®Google Scholar
• Shabsigh R, Duval S, Shah M, Regan TS, Juhasz M, Veltry LG. Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. Curr Med Res Opin 2007;23:2453–60
   PubMed Web of Science ®Google Scholar
• Donatucci C, Eardley I, Buvat J, et al. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification. J Sex Med 2004; 1:301–9
   PubMed Web of Science ®Google Scholar